Paul Kemp attends BIOtrachea FP7 Annual Meeting in Stockholm

Paul Kemp recently attended the annual meeting of BIOtrachea FP7 project in Stockholm.

The BIOtrachea project is managed by the BIOtrachea EU consortium, consisting of 13 EU-based, clinical, academic, and commercial participants, including Intercytex Ltd. The project is partially funded by the European Commission.

To learn more, please visit the BIOtrachea project website at www.biotrachea.eu

E-mail Print PDF